{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:47:15Z","timestamp":1792403235702,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":171,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.ctarc.2022.100595","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T16:49:34Z","timestamp":1656434974000},"page":"100595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["EARS2 significantly coexpresses with PALB2 in breast and pancreatic cancer"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4850-094X","authenticated-orcid":false,"given":"Steven","family":"Lehrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Rheinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2022.100595_bib0001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2022.100595_bib0002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/2211-5463.12356","article-title":"High expression of PALB2 predicts poor prognosis in patients with advanced breast cancer","volume":"8","author":"Li","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ctarc.2022.100595_bib0003","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s10038-019-0612-6","article-title":"PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk","volume":"64","author":"Vagena","year":"2019","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ctarc.2022.100595_bib0004","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/cncr.28662","article-title":"BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts","volume":"120","author":"Lucas","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2022.100595_bib0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/gim.2014.153","article-title":"BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study","volume":"17","author":"Zhen","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.ctarc.2022.100595_bib0006","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s11605-019-04230-z","article-title":"Surgical outcomes after pancreatic resection of screening-detected lesions in individuals at high risk for developing pancreatic cancer","volume":"24","author":"Canto","year":"2020","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.ctarc.2022.100595_bib0007","unstructured":"PALB2. The human protein atlas https:\/\/www.proteinatlas.org\/ENSG00000083093-PALB2\/pathology retrieved 19 August 2021."},{"key":"10.1016\/j.ctarc.2022.100595_bib0008","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10689-011-9426-1","article-title":"PALB2 mutations in familial breast and pancreatic cancer","volume":"10","author":"Hofstatter","year":"2011","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.ctarc.2022.100595_bib0009","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal"},{"key":"10.1016\/j.ctarc.2022.100595_bib0010","author":"Shahriyari","year":"2017","journal-title":"Effect of Normalization Methods On the Performance of Supervised Learning Algorithms Applied to HTSeq-FPKM-UQ Data sets: 7SK RNA Expression As a Predictor of Survival in Patients With Colon Adenocarcinoma"},{"key":"10.1016\/j.ctarc.2022.100595_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ctarc.2022.100595_bib0012","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.2440","article-title":"The Human Protein Atlas\u2014A tool for pathology","volume":"216","author":"Pont\u00e9n","year":"2008","journal-title":"The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland"},{"key":"10.1016\/j.ctarc.2022.100595_bib0013","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ctarc.2022.100595_bib0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3102\/10769986027001077","article-title":"Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons","volume":"27","author":"Thissen","year":"2002","journal-title":"J. Educ. Behav. Stat."},{"key":"10.1016\/j.ctarc.2022.100595_bib0015","doi-asserted-by":"crossref","unstructured":"Goldman M., Craft B., Zhu J., Haussler D. (2017) The UCSC Xena system for cancer genomics data visualization and interpretation. Annual Meeting Proceedings AACR.","DOI":"10.1158\/1538-7445.AM2017-2584"},{"key":"10.1016\/j.ctarc.2022.100595_bib0016","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1038\/ncomms11479","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2022.100595_bib0017","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2022.100595_bib0018","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ctarc.2022.100595_bib0019","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jns.2016.04.008","article-title":"Leukoencephalopathy with thalamus and brainstem involvement and high lactate caused by novel mutations in the EARS2 gene in two siblings","volume":"365","author":"\u015eahin","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ctarc.2022.100595_bib0020","article-title":"Molecular basis of Leigh syndrome: a current look","volume":"15","author":"Schubert","year":"2020","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ctarc.2022.100595_bib0021","unstructured":"EARS2. The human protein atlas https:\/\/www.proteinatlas.org\/ENSG00000103356-EARS2\/pathology retrieved 19 August 2021."},{"key":"10.1016\/j.ctarc.2022.100595_bib0022","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2147\/OTT.S297134","article-title":"Identification of metabolic-associated genes for the prediction of colon and rectal adenocarcinoma","volume":"14","author":"Cui","year":"2021","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.ctarc.2022.100595_bib0023","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-019-05446-y","article-title":"Research-based PAM50 signature and long-term breast cancer survival","volume":"179","author":"Pu","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ctarc.2022.100595_bib0024","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3892\/ol.2021.12485","article-title":"PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma","volume":"21","author":"Ge","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ctarc.2022.100595_bib0025","article-title":"High BRCA2 gene expression is associated with aggressive and highly proliferative breast cancer","author":"Satyananda","year":"2021","journal-title":"Ann. Surg. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294222000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294222000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:34:22Z","timestamp":1762842862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294222000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":25,"alternative-id":["S2468294222000855"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2022.100595","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EARS2 significantly coexpresses with PALB2 in breast and pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2022.100595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100595"}}